KRAS and pancreatic ductal adenocarcinoma: Mutant KRAS-G12V induces pancreatic ductal adenocarcinoma in mice when expressed in embryonic acinar lineage cells whereas chronic pancreatitis is needed for KRAS-G12V to induce pancreatic tumors in adult mice [5].